NCT04863183View on ClinicalTrials.gov

Cell Therapy With Cellistem-OA for Symptomatic Knee Osteoarthritis

PHASE1/PHASE2UnknownINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

June 1, 2021

Primary Completion Date

December 31, 2021

Study Completion Date

June 30, 2022

Conditions
Mesenchymal Stem CellsKnee OsteoarthritisCell Therapy
Interventions
BIOLOGICAL

CELLISTEM-OA

The intra-articular puncture will be performed by an orthopedic doctor specializing in knee and hip treatments. The procedure will be carried out using sterile technique, after cooling the skin with local ice.

DRUG

Triamcinolone acetonide

The intra-articular puncture will be performed by an orthopedic doctor specializing in knee and hip treatments. The procedure will be carried out using sterile technique, after cooling the skin with local ice.

Sponsors

Collaborators (1)

Cells for Cells
All Listed Sponsors
collaborator

Cells for Cells

INDUSTRY

lead

Fundación Oftalmológica de Santander Clínica Carlos Ardila Lulle

OTHER